🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

After closing a $60M Series A financing led by Madrona, today we officially launched Terray Therapeutics – a #biotech with the chemistry engine and #AI to propel #drugdiscovery into the information age. Learn more here: terraytx.com #biotechnews

Excited to announce our investment in Terray Therapeutics today! Read more from Chris Picardo on this Intersections of Innovation company and why invested. madrona.com/intersections-…

tNova is our #AI-driven drug discovery platform that operates at an unrivaled scale, using #MachineLearning to become increasingly precise with each cycle of virtual molecular design and measurement. This is the chemistry engine that puts transformative therapeutics within reach.

Thank you Madrona for the opportunity to talk about how Terray got its start and how the difference in our approach comes from the data. Check out the chat with Narbe Mardirossian and Chris Picardo to learn more and hear what @JacobBerlinPhD was like in high school. 👨‍🎓

Terray is thrilled to welcome Feroze (Fez) Ujjainwalla as Head of Business and Adam D. Hughes as Head of Chemistry. Read more about how Fez and Adam will bolster Terray's world-class management team: terraytx.com

We’re proud to support Terray investor and friend Sabah Öney (Sabah Öney) and the entire expedition team led by Luke Timmerman (Luke Timmerman) as they climb to Mt. Everest Base Camp to support the Fred Hutchinson Cancer Center Climb to Fight Cancer. @climbtofight

We're honored to support an extraordinary cause!

Congratulations to @SabahOney and everyone on Team Timmerman on completion of their @climbtofight expedition! We’re honored to have supported Fred Hutchinson Cancer Center and to contribute to funding research to end cancer. 📸: Luke Timmerman

Did you miss @JacobBerlinPhD and Eli Berlin on Madrona’s podcast Founded and Funded? Don’t miss their conversation about lessons learned and the future of #AI in biotechnology: madrona.com/founded-and-fu…

Our executive team of pioneers and long-time leaders in #AI, medicinal #chemistry, #biology, #automation, and #nanotechnology have a vision to create a world where transformative therapeutics are at our fingertips. Ready to join #TeamTerray? We are #nowhiring! #biotechjobs

We're beyond excited to be a part of the AWS Startups Startup Innovation Series - come join @JacobBerlinPhD, Eli Berlin, and Narbe Mardirossian as they talk about building a #biotech company and how we're using #AI in #DrugDiscovery. bit.ly/AWSTerray

Have you marked your calendar for June 2nd? We’ll be chatting with Mark Birch Community Builder and Chris Cheng for the AWS Startup Innovation Series, and you won’t want to miss it. Save the date: bit.ly/AWSTerray #biotech #startup #AI #DrugDiscovery

Tonight’s the night! We hope to see you on Clubhouse at 6 PM EDT for “Using chemistry data & AI to speed drug discovery”, the last of @Amazon Web Service’s Startup Innovation series! bit.ly/AWSTerray #biotech #startup #chemistry #AI #DrugDiscovery

Our CEO @JacobBerlinPhD will be presenting at Morgan Stanley's Putting the Tech in Biotech conference tomorrow to discuss how Terray is meeting the challenge of #DrugDevelopment with the chemistry engine and #AI to propel drug discovery into the information age. #biotech

We are thrilled to announce the appointment of Fiona Black, PhD, to our Scientific Advisory Board. Read more about Fiona and how she will support Terray’s mission to advance drug discovery: terraytx.com

You won’t want to miss this – mark your calendars for Terray’s panel at TechCrunch’s #Disrupt2022! We’re beyond excited to talk about solving science's hardest problems at scale with our friends at BigHat Biosciences!

Terray is proud to announce a multi-target collaboration with Calico. The Terray and Calico teams will work together to discover and develop small molecule therapeutics for diseases of aging, including cancer. Read more here: prnewswire.com/news-releases/…

We are pleased to announce a new collaboration with Terray Therapeutics focused on the discovery and development of novel small molecule therapeutics for diseases of #aging, including #cancer. To learn more: bit.ly/3VnQvLM

Today’s the day! We hope to see you at 10 am PDT for “Tech-Driven Biology and Chemistry: Solving Science’s Hardest Problems at Scale” at #Disrupt2022. We'll be talking with BigHat Biosciences and Amazon Web Services about: 🟢 Company Building 🟢 Science Fact vs Fiction 🟢 The Future of Medicine

Thanks to all the attendees and partners who came out for TechCrunch Disrupt to check out AWS’ breakout session with founders from BigHat Biosciences & Terray Therapeutics, and the AWS San Francisco Startup Loft afterparty. 🎉 For more on AWS Startup Loft events, visit: go.aws/3SzJx3O